The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy.

Overview of attention for article published in Clinical Cancer Research, November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 40 X posts from 29 X users, with an upper bound of 65,268 followers.

RT @Marlowe_Tessmer: New Review @CCR_AACR from @gmicevic, Marcus W. Bosenberg & @QinYan1 @YaleCancer @YaleMed The Crossroads of Cancer Ep…

RT @QinYan1: Great to learn that our review with @gmicevic, Marcus Bosenberg, was highlighted! @yalepathology @YaleCancer @YaleMed

RT @Marlowe_Tessmer: New Review @CCR_AACR from @gmicevic, Marcus W. Bosenberg & @QinYan1 @YaleCancer @YaleMed The Crossroads of Cancer Ep…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 36 additional X posts.